FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
- Status
- TERMINATED
- Phase
- PHASE1
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
CAR T-cell Therapy in Patients With Renal Dysfunction
- Status
- RECRUITING
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Delayed Tolerance Through Mixed Chimerism
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
- Status
- RECRUITING
- Phase
- N/A
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
- Status
- UNKNOWN
- Phase
- PHASE2
Influence of Timing PTCy in AlloSCT
- Status
- COMPLETED
- Phase
- N/A
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
- Status
- TERMINATED
- Phase
- PHASE2
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1